These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7262510)

  • 21. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma amino acid changes in 40 cases of chronic cor pulmonale].
    Xiao L
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Oct; 12(5):272-4, 317-8. PubMed ID: 2632032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma amino acid levels in alcoholics].
    Saito T; Watanabe M; Nakamura K; Yanbe K; Shirasaka T; Ogata M
    Arukoru Kenkyuto Yakubutsu Ison; 1993 Jun; 28(3):120-7. PubMed ID: 8347103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between zinc, amino acids and ammonia in liver cirrhosis.
    Grüngreiff K; Presser HJ; Franke D; Lössner B; Abicht K; Kleine FD
    Z Gastroenterol; 1989 Dec; 27(12):731-5. PubMed ID: 2626852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of parenteral amino acid administration on the brain function and the serum aminogram of patients with liver cirrhosis].
    Leweling H; Knauff HG; Nitschke J; Paquet KJ
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):88-94. PubMed ID: 6776054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior of conjugated bile acids in the serum during liver diseases].
    Paumgartner G; Grabner G
    Acta Hepatosplenol; 1970; 17(5):344-53. PubMed ID: 5516233
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report).
    Fiaccadori F; Ghinelli F; Pelosi G; Sacchini D; Vaona GL; Zeneroli ML; Rocchi E; Santunione V; Gibertini P; Ventura E
    Ric Clin Lab; 1980; 10(2):411-22. PubMed ID: 7455531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy.
    Ichida T; Shibasaki K; Muto Y; Satoh S; Watanabe A; Ichida F
    Nutrition; 1995; 11(2 Suppl):238-44. PubMed ID: 7626911
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation.
    Tietge UJ; Bahr MJ; Manns MP; Böker KH
    Transpl Int; 2003 Jan; 16(1):1-8. PubMed ID: 12545334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional support of patients with severe hepatic failure.
    Barber JR; Teasley KM
    Clin Pharm; 1984; 3(3):245-53. PubMed ID: 6428797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy.
    Minuk GY; Winder A; Burgess ED; Sarjeant EJ
    Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.
    Udayakumar N; Subramaniam K; Umashankar L; Verghese J; Jayanthi V
    J Clin Gastroenterol; 2007; 41(10):922-6. PubMed ID: 18090162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases.
    Yagmur E; Trautwein C; Gressner AM; Tacke F
    Am J Gastroenterol; 2006 Jun; 101(6):1244-52. PubMed ID: 16771945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoacid imbalance ratio in liver disease.
    Maqsood R; Zuberi SJ
    J Pak Med Assoc; 1976 Jun; 26(6):145-6. PubMed ID: 826659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum viscosity and chronic hepatopathies].
    Pavanel S; Dell'Anna L; Cappelletti P
    Quad Sclavo Diagn; 1983 Mar; 19(1):98-112. PubMed ID: 6675048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy.
    Keshavarzian A; Meek J; Sutton C; Emery VM; Hughes EA; Hodgson HJ
    Am J Gastroenterol; 1984 Dec; 79(12):945-9. PubMed ID: 6391154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
    Schulte-Frohlinde E; Wagenpfeil S; Willis J; Lersch C; Eckel F; Schmid R; Schusdziarra V
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1241-8. PubMed ID: 17688664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gc-globulin in liver disease.
    Schiødt FV
    Dan Med Bull; 2008 Aug; 55(3):131-46. PubMed ID: 19232164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.